MDT vs SYK
MDT: Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain, restore health, and extend life across 150+ countries. SYK: A diversified medical technology leader offering surgical equipment, orthopedic robotics, and minimally invasive neurovascular products that collectively serve over 150 million patients annually across 61 countries.
Side-by-side fundamentals
| Metric | MDT | SYK | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $82.39 | $327.11 | |
| Market cap as of 2026-07-10 | $104.8B | $126.0B | |
| P/E as of 2026-07-10 | 21.81 | 37.74 | MDT lower |
| PEG as of 2026-07-10 | 2.90 | 3.29 | MDT lower |
| Net margin as of 2026-07-10 | +13.2% | +13.2% | Tie |
| Gross margin as of 2026-07-10 | +65.3% | +64.2% | MDT higher |
| Operating margin as of 2026-07-10 | +17.8% | +19.7% | SYK higher |
| ROE as of 2026-07-10 | +9.8% | +15.1% | SYK higher |
| ROA as of 2026-07-10 | +5.2% | +7.1% | SYK higher |
| Debt / equity as of 2026-07-10 | 0.57 | 0.64 | MDT lower |
| Revenue growth (YoY) as of 2026-07-10 | +8.4% | +8.8% | SYK higher |
| Revenue CAGR (3y) SEC XBRL | +5.2% | +10.8% | SYK higher |
| Dividend yield as of 2026-07-10 | +3.5% | +1.1% | MDT higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-10 | 0.58 | 0.78 | |
| 1-year return as of 2026-07-09 close | -7.4% | -16.6% | MDT higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.